Sun builds controlled substances play with GSK opiates buy
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries has acquired GlaxoSmithKline's opiates business in Australia – a move that is expected to help the Indian firm build significantly on its interests in the controlled substances space.